ELISpot plates (Millipore, Bedford, MA, United States) were coated with 2 μg/ml ID93 and incubated overnight at 4°C. Plates were washed with PBS, blocked with complete RPMI and 10% FBS for 2 h, at room temperature, and then washed again. Single-cell suspensions from harvested bone marrow were prepared as described above and seeded at 1.5×10
6 cells per well. The plates were then incubated at 37°C with 5% CO2 for 3 h, washed, and HRP-conjugated anti-mouse IgG (H + L) or IgA antibodies (Southern Biotech, Birmingham, AL, United States) were added for overnight incubation at 4°C. The plates were developed with AEC substrate kits according to the manufacturer’s protocol (Vector Laboratories, Burlingame, CA, United States). Spots were counted using an automated ELISPOT reader (
CTL. Analyzer, Cellular Technology Ltd., Shaker Heights, OH, United States). Data were analyzed using ImmunoSpot® software (CTL Analyzer).
Gomez M., Ahmed M., Das S., McCollum J., Mellett L., Swanson R., Gupta A., Carrigy N.B., Wang H., Barona D., Bachchhav S., Gerhardt A., Press C., Archer M.C., Liang H., Seydoux E., Kramer R.M., Kuehl P.J., Vehring R., Khader S.A, & Fox C.B. (2022). Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse Model. Frontiers in Pharmacology, 12, 799034.